Skip to content

A Training Program of Drug Allergy for Healthcare Professionals

A Training Program of Drug Allergy for Healthcare Professionals: A Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06399601
Enrollment
100
Registered
2024-05-06
Start date
2024-12-09
Completion date
2024-12-16
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Allergy

Keywords

Drug allergy

Brief summary

Drug allergy is often under-recognized, yet over- (mistakenly) diagnosed, especially in Hong Kong. There is also a dire shortage of allergy specialists and facilities to tackle the overwhelming drug allergy pandemic. Fortunately, when trained, non-specialist physicians and nurses have demonstrated comparable capabilities in drug allergy evaluation compared to specialists. To potentially promote and propagate the role of non-specialist physicians and nurses toward drug allergy care, the investigators propose a study to investigate the impact of an intensive and focused drug allergy educational course conducted at the University of Hong Kong.

Detailed description

Two identical didactic courses on drug allergy were designed. Each course will last 12 hours and conducted over 2 consecutive days (6 hours each day). All candidates will attend physically and on-site. Various aspects of drug allergy with pre-set learning objectives will be taught in-person by instructors (physicians or nurses specializing in drug allergy nominated by the University of Hong Kong). Course materials and instructors will be identical for each course. Aims of the study Primary objective * Investigate the change in knowledge among participants of a 2-day drug allergy educational course * Investigate the change in clinical practice among participants of a 2-day drug allergy educational course Secondary objectives * Investigate the sustained change(s) in knowledge (if any) of participants of a 2-day drug allergy educational course * Investigate the sustained change(s) in clinical practice (if any) of participants of a 2-day drug allergy educational course Hypothesis The investigators hypothesize that candidates (practicing physicians and nurses) of the drug allergy course will gain knowledge on drug allergy, which in turn will influence and change their clinical practice.

Interventions

OTHERDrug allergy training program

Two identical didactic courses on drug allergy were designed. Each course will last 12 hours and conducted over 2 consecutive days (6 hours each day). All candidates will attend physically and on-site. Various aspects of drug allergy with pre-set learning objectives will be taught in-person by instructors (physicians or nurses specializing in drug allergy nominated by the University of Hong Kong). Course materials and instructors will be identical for each course.

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Registered nurses or doctors actively practicing in Hong Kong * English speaking; * Able to complete quizzes and questionnaires; * Aged 18 or above

Exclusion criteria

* People who are unable to communicate in Cantonese or Mandarin * People who are participating in other drug allergy training course

Design outcomes

Primary

MeasureTime frameDescription
Change in knowledge of drug allergy as measured by the validated drug allergy questionnaireAfter the 2-day training courseKnowledge includes mechanism, clinical manifestations, diagnosis and management of drug allergy. A binary variable scale were used to ascertain level of the knowledge (from 0 to 1: 0, wrong; 1, right). Answers formats consisted of 4-choice questions (total 14 questions).

Countries

Hong Kong

Contacts

Primary ContactHei Li, MBBS
liphilip@hku.hk2255 5995

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026